David Mundell MP: speeches

Speeches

• 17 Jun 2025 · Crime and Policing Bill · Hansard source

  More

  Given the strictures on time, I had better not. Previous Ministers said that there was no need for specific legislation on spiking, because it was already covered. Campaigning, including by your colleague, Madam Deputy Speaker, the First Deputy Chairman of Ways and Means, the hon. Member for Bradford South (Judith Cummins), and by my former colleague, Richard Graham, demonstrated that there was a need for a specific measure, and that if we are going to have a specific measure, it needs to bring certainty. Part of that certainty is for the benefit of the police and others. The police should know that that reckless behaviour is also a crime, and there should not be any dubiety when they arrive at a venue to find someone in a partially conscious state or unable to articulate what has happened to them. It will also allow campaigning to be clear that whatever the circumstances, a drink is spiked or a person is injected, and that is a crime. Amendment 19—or perhaps another amendment that the Government might bring forward in the other place—would bring clarity, which is important. That is what we need to bring about. As the hon. Member for Hitchin said, that can lead to the greater training of the police and NHS workers to be able to support people in a spiking situation. I hope the Minister will reflect on everything that has been said today. The final point I will make relates particularly to Scotland. We need to have a common approach across the UK; it should not matter whether somebody is spiked in Glasgow, Manchester or Cardiff. That is not to disrespect the devolution settlement and the different approaches of the criminal justice system. The effect and the impact should be the same wherever people are, and the criminality should most certainly be the same, whether the behaviour is intentional or reckless.

• 17 Jun 2025 · Crime and Policing Bill · Hansard source

  More

  I rise to support amendment 19, in the name of my hon. Friend the Member for Isle of Wight East (Joe Robertson). I hope that the Minister listened to the compelling case that my hon. Friend made, and to the compelling case made by the hon. Member for Hitchin (Alistair Strathern) on the issue of spiking more generally. I want to put on record my support for my constituents, Colin and Mandy Mackie, and their organisation, Spike Aware UK. I do not think any of us can fully comprehend their experience: the police knocked on their door to tell them that their 18-year-old son had died at college from a drug overdose, but they subsequently found out that his non-alcoholic drink had been spiked by five ecstasy tablets. As other Members have said, there was no support or help for the family in that situation. The police assumed that he had died of a drug overdose although they did not know that, and they subsequently apologised to the Mackies for their treatment of them. What I particularly admire about Colin and Mandy is how they have focused their efforts on ensuring that their experience is not shared by anyone else. That is why I very much welcome the inclusion of spiking in the Bill, which is a continuation from the Criminal Justice Bill introduced in the previous Parliament. The point to be made is about certainty, and the amendment tabled by my hon. Friend the Member for Isle of Wight East brings certainty to the situation. I have been in this House with previous Ministers who have been told by officials that spiking was already covered by legislation, and therefore there was no need for specific mention of spiking.

• 5 Jun 2025 · Business of the House · Hansard source

  More

  Will the Leader of the House bring forward a specific debate that focuses on the 80th anniversary of VJ Day and the end of the war in the far east, so that the horrific conditions in which those, for example, in the King’s Own Scottish Borderers had to fight and the conditions that people faced as prisoners of war can be properly recognised? We had a debate on the 80th anniversary of VE Day, but—as in 1945—the end of the war in Europe overshadowed those events in the far east.

• 30 Jan 2025 · Medicinal Cannabis · Hansard source

  More

  The right hon. Gentleman makes a very good point. Indeed, over time, I think all of us who have taken an interest in this issue have heard from multiple sclerosis sufferers about the pain and difficulties that they have encountered. It is incumbent on us, those in Government and those in the medical world to do what we can to make sure that that is no longer the case. I want to focus my remarks on the economic case for medical cannabis. I will talk about the contribution that a different and more progressive approach could make to the economies of rural constituencies such as mine—those were some of the points that I touched on in the previous debate—because, at its core, the nascent medical cannabis sector is horticultural in character and is situated in rural and agricultural communities such as the one I represent. In my constituency, I see Hilltop Leaf develop growing and processing facilities that are pristine and equipped with high-tech quantum sensors, microscopes or leaf barometers. It is a stark contrast to the damp tinfoil-wrapped rooms of illegal production, referred to earlier. It is certainly a marked contrast to the circumstances in which some people feel forced to acquire cannabis and the dangers and difficulties that they place themselves in through doing that. As the hon. Member for Strangford said, they do that because they love the person who is suffering. They do not want to see them suffer, and they are willing to take risks and do things that they would not otherwise consider. In that context, it is all the more important that we see the industry—a modern, progressive industry—as a step forward. I enormously support the investment in my constituency. I particularly hope that good horticultural, administrative, managerial and logistics jobs, which will anchor the young people in the constituency, will flow from it; young people all too often feel the need to leave such communities for the want of opportunities. The facilities at Hilltop should also be able to provide some 10% of the UK’s medical cannabis needs. I have hopes that Hilltop can go further still, because the medical cannabis sector could potentially bring more than £1 billion to the UK economy. I do not wish to divert into the Chancellor’s remarks about economic growth, Dame Esther, because we have heard a lot about that in the Chamber. But this industry is there and ready to grow—ready to create wealth and jobs, particularly in some of the most difficult rural environments in the UK. It has been estimated that tens of thousands of good quality jobs could be created if the UK’s regulatory, legal and medical frameworks were in line with norms elsewhere. Sadly, byzantine rules on prescribing and overlapping and onerous regulations are holding the sector back. Medical cannabis was legalised in 2018 by my former colleague Sajid Javid, then the Home Secretary, but it remains unduly difficult to prescribe on the NHS across every part of the United Kingdom. Those in need—we should be clear that this is a matter of need—turn to private medical services, with the huge costs that they bring; the hon. Member for Strangford also highlighted that. They turn to criminals as well. It is absurd to make something of medicinal benefit legal, but for it to be put out of the reach of so many people who need it. The situation has a knock-on effect on the sector. In recent years, we exported 213 tonnes of medical and scientific cannabis of the 329 tonnes produced in the UK. The sector could meet domestic patients’ needs and international demands, but incoherence in regulation and approach is hindering that. That also extends to cannabidiol or CBD, which has many benefits too. It is readily available to purchase on the high street, so much so that the CBD market in the UK is the second largest globally. However, hemp licensing laws mean that the flowers and leaves where CBD is found must be destroyed. Overseas imports then fulfil the needs of the domestic CBD market, and British supply chains do not benefit. Because of that approach, growers have to forsake the opportunity of a crop yielding £10,000 per acre, compared to £400 for wheat. At a time when rural Britain is struggling, such yields would be a real boon and bring income into the pockets of farmers. Patients, producers, taxpayers and even the police, as the hon. Member for Strangford mentioned, could all benefit from unblocking the bottlenecks in prescription and production. As I have said on many occasions, for that to happen the various strands of Government need to be stitched together. Instead of keeping the strange patchwork of overlapping and clashing components, there needs to be a clear policy of supporting the prescription of medical cannabis, and the necessary regulation and official approach that would allow that to happen. The UK Government and, where appropriate, the devolved Administrations should review the prescription process, medical guidelines, acceptable technical levels and the overlapping regulatory and legal regimes. We have debated and discussed this issue many times. I hope that we will see some progress and that we do not have to repeatedly debate an issue to which we should have a common-sense approach. It benefits patients and our economy. It has an adverse effect on criminals. Why would we not do it?

• 27 Nov 2024 · World AIDS Day · Hansard source

  More

  Thank you, Sir Mark. I will simply agree with what both the previous speakers have said. I commend the hon. Member for Uxbridge and South Ruislip (Danny Beales) for securing this debate and for his work with the National AIDS Trust. I positively support its report, along with the Terrence Higgins Trust and the Elton John AIDS Foundation, “Getting on track”, and I am pleased that the Minister has engaged with that report already. As co-chair of the all-party parliamentary group on HIV, AIDS and sexual health, I will focus on the global issues. We have already heard that there were 1.3 million new transmissions last year, and in sub-Saharan Africa, 62% of those infections were among women and girls. I have three asks of the UK Government. First, I ask that they continue to be a major contributor to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Since 2002, the UK has committed over £5.4 billion, making it one of the largest donors, and it is extremely important that it continues to do so. Secondly, the UK needs to focus on expanding access to antiretroviral therapy—ART—for people living with HIV. ART is a lifesaving treatment that not only improves the health and quality of life of individuals but reduces the risk of HIV transmission. Thirdly, the UK needs to be a leader in confronting anti-LGBT+ legislation globally. We know that the risk of arrest and criminality leads people to hide their sexuality, avoid testing and eschew treatment, because they are evidence of so-called subversive or criminal behaviours. Such laws are an impediment to progress and undermine the efforts of the UK to assist health systems. We must stand up against them, and I hope the Minister will confirm that.